Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production
Arthritis & Rheumatology · 2023
DOI: 10.1002/art.42435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von Iris K Madera-Salcedo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Nephritis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Council of Science and Technology, Mexico, Fundación Miguel Alemán, A.C..
Abstract (Originalsprache)
Objective
Variants in STAT4 are associated with systemic lupus erythematosus (SLE) and other autoimmune diseases. We undertook this study to investigate how disease‐associated variants affect STAT4 expression, in particular in CD4+ T cells where STAT4 plays an essential role.
Methods
We compared Th1 differentiation between naive CD4+ T cells from healthy donors homozygous for the risk (R/R) or nonrisk (NR/NR) alleles. We analyzed epigenetic marks in STAT4 and evaluated the relevance of its third intron, assessed the consequences of Stat4 overexpression in vivo in mice, and analyzed the effects of the STAT4 genotype in patients with lupus nephritis.
Results
Naive CD4+ T cells from NR/NR healthy donors down‐regulated STAT4 in response to interleukin‐12 (IL‐12). In contrast, cells from R/R healthy donors maintained high levels. R/R cells exhibited a higher abundance of transcriptionally active STAT4 and increased interferon‐γ production. Accordingly, R/R healthy donors exhibited a stronger induction of local active enhancer marks. Genetic editing confirmed the presence of a negative regulatory region in the STAT4 third intron, where most of the SLE‐associated STAT4 single‐nucleotide polymorphisms (SNPs) are located. In vivo forced expression demonstrated that increases in Stat4 levels in T cells enhanced glomerulonephritis in mice. Accordingly, the R/R genotype was associated with suboptimal response to treatment and with worse clinical outcomes in patients with proliferative lupus nephritis.
Conclusion
The SLE‐associated STAT4 haplotype correlates with an abnormal IL‐12–mediated STAT4 transcriptional regulation. Carriers of the risk variant exhibit exaggerated CD4+ proinflammatory capacities that, in the context of SLE, contribute to more severe disease. R/R patients may benefit from blockade of the IL‐12/STAT4 pathway. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, and Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, M…
- Animal Research Facility, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and Plan de Estudios Combinados en Medicina (PECEM), Facultad de Medicina, UNAM, Mexico City, Mexico.
- Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Ciudad Universit…
ORCID-Profile: Iris K Madera-Salcedo, Gerardo Suárez-Rojas, Juan Manuel Mejía-Vilet, Florencia Rosetti
Förderung
- National Council of Science and Technology, Mexico
- Fundación Miguel Alemán, A.C.
Zitieren
APA
Madera-Salcedo, I. K., Ramírez-Sánchez, A. L., Rodríguez-Rodríguez, N., García-Quintero, R., Rubio, R. M., Morales-Montes de Oca, G., Dávalos, E., Cuervo, R., Furuzawa-Carballeda, J., Alcocer-Varela, J., Gómez-Martín, D., González-Yáñez, M., de la Cruz, A., Albarrán-Godínez, A., Suárez-Rojas, G., Romero-Díaz, J., Uribe-Uribe, N. O., Alarcón-Riquelme, M., Furlan-Magaril, M., …, & Rosetti, F. (2023). Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production. Arthritis & Rheumatology. https://doi.org/10.1002/art.42435
Vancouver
Madera-Salcedo IK, Ramírez-Sánchez AL, Rodríguez-Rodríguez N, García-Quintero R, Rubio RM, Morales-Montes de Oca G, et al. Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production. Arthritis & Rheumatology. 2023. doi:10.1002/art.42435
BibTeX
@article{MaderaSalcedo2023,
author = {Madera-Salcedo, Iris K and Ramírez-Sánchez, Ada L and Rodríguez-Rodríguez, Noé and García-Quintero, Roberto and Rubio, Rosa M and Morales-Montes de Oca, Gabriela and Dávalos, Emmanuel and Cuervo, Rogelio and Furuzawa-Carballeda, Janette and Alcocer-Varela, Jorge and Gómez-Martín, Diana and González-Yáñez, Marysol and de la Cruz, Abigail and Albarrán-Godínez, Adrián and Suárez-Rojas, Gerardo and Romero-Díaz, Juanita and Uribe-Uribe, Norma O and Alarcón-Riquelme, Marta and Furlan-Magaril, Mayra and Mejía-Vilet, Juan Manuel and Crispín, José C and Rosetti, Florencia},
title = {Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production},
journal = {Arthritis & Rheumatology},
year = {2023},
doi = {10.1002/art.42435}
}
EUVIMED